45 results
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
totaling RMB 3.7 million (USD 0.5 million) and a research and development tax incentive from the Australia government totaling RMB 6.3 million (USD 0.9 … Compensation
2019 Stock Incentive Plan
The Group adopted the 2019 Stock Incentive Plan (“2019 Plan”) and obtained Board’s approval on November 1, 2019, under
6-K
vlv9s1qi impao
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
S-8
emzqwd1lu56b
1 Jul 22
Registration of securities for employees
5:12pm
S-8
EX-5.1
l2q3n4ggrq47u sk91
1 Jul 22
Registration of securities for employees
5:12pm
S-8
1gu7 21zt46o6
1 Jul 22
Registration of securities for employees
5:12pm
F-3/A
e4a4hp
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
7k2ypflwldfs7 y8z
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
EX-1.2
br2mkou 5w
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
ok08s1g
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
xqdc 6z8st
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.5
e52kkp3k
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
qzpzk 1tc1o90
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.10
t70g86eo6g9s
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-1.1
ju3 hb57rb0g
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
kv68bjl4fe f5t04b
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
3ez0f
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm